Hyperglycemia, diabetes and stroke: Focus on the cerebrovasculature
- Adviye Ergul(corresponding author),
- Weiguo Li,
- Mostafa M. Elgebaly,
- ,
- Susan C. Fagan
- ,
- College of Pharmacy,
- ,
- Augusta University,
- Charlie Norwood VA Medical Center
Scholary Output:
Contribution to journal
Article
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Acute ischemic stroke (AIS) results from the occlusion of an artery and causes vascular and neuronal damage, both of which affect the extent of ischemic injury and stroke outcome. Despite extensive efforts, there is only one effective treatment for AIS. Given that up to 40% of the AIS patients present with admission hyperglycemia either as a result of diabetes or acute stress response, targets for neuronal and vascular protection under hyperglycemic conditions need to be better defined. Here, we review the impact of diabetes and acute hyperglycemia on experimental stroke with an emphasis on cerebrovasculature structure and function. The relevance to clinical evidence is also discussed.
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 44-49 (6 pages)Journal (Volume, Issue Number)
Vascular Pharmacology (Volume 51, Issue 1)Publication milestones
- Published - 07/2009
Publication status
Published - 07/2009
ISSN
1537-1891Publication IDs
- Scopus: 67349179497
- PubMed: 19258053
Publication metrics
Metrics
Fractional count
3
Fractional count
0.60
Fractional count
2
Fractional count
0.40
Fractional count
3
Fractional count
1
SciVal
FWCI
2.02
SciVal
Author count
5
SciVal
citations
78
SciVal
Paper percentile
94
SciVal
Top percentile
10
PlumX, opens in new tab
Captures
88
Citation count
100
Funding Details
This work was supported by grants from NIH (NS054688, DK074385) and American Heart Association Established Investigator Award to Adviye Ergul and NIH (NS044216), VA Merit Review and American Heart Association-SE affiliate to Susan C. Fagan.
FundersFunding numbers
NIH
NS054688, DK074385
NINDS
R01NS044216
AHA
NS044216
